Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AIM CVE:GMN TSE:OLY TSE:URB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMAIM ImmunoTech$2.70+0.4%$6.55$2.33▼$39.00$2.06M0.8866,661 shs71,785 shsGMNGobiMinC$1.83C$1.83C$0.20▼C$1.84C$89.78M0.7628,832 shs167,000 shsOLYOlympia Financial GroupC$131.00-0.5%C$124.13C$95.51▼C$134.24C$315.23M0.271,944 shs1,060 shsURBUrbanaC$7.25-0.5%C$6.77C$5.00▼C$7.39C$291.85M0.72,534 shs6,811 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMAIM ImmunoTech+0.37%+1.89%-68.05%-70.46%-93.15%GMNGobiMin0.00%0.00%0.00%0.00%0.00%OLYOlympia Financial Group-0.54%-0.15%+5.65%+23.54%+16.86%URBUrbana-0.55%+2.26%+5.53%+17.31%+41.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMAIM ImmunoTech1.4022 of 5 stars3.50.00.00.02.10.00.0GMNGobiMinN/AN/AN/AN/AN/AN/AN/AN/AOLYOlympia Financial Group3.021 of 5 stars2.50.02.50.01.93.31.3URBUrbanaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMAIM ImmunoTech 3.00Buy$275.0010,085.19% UpsideGMNGobiMin 0.00N/AN/AN/AOLYOlympia Financial Group 3.00BuyC$147.9112.91% UpsideURBUrbana 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMAIM ImmunoTech$121K17.05N/AN/A$0.20 per share13.50GMNGobiMinC$28.61K3,137.84C$3.22 per share0.57C$1.89 per share0.97OLYOlympia Financial GroupC$102.64M3.07C$11.24 per share11.66C$16.72 per share7.83URBUrbanaC$32.17M9.07C$0.01 per share1,080.00C$10.32 per share0.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMAIM ImmunoTech-$28.96M-$24.68N/AN/AN/A-12,594.21%-421.73%-147.54%N/AGMNGobiMin-C$10.43M-C$0.29N/A∞N/A83,354.28%-13.01%-3.82%N/AOLYOlympia Financial GroupC$24.45MC$10.1612.89∞N/A23.82%64.95%35.88%N/AURBUrbanaC$66.13MC$1.694.28∞N/A205.53%16.84%16.83%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMAIM ImmunoTechN/AN/AN/AN/AN/AGMNGobiMinN/A4.35%N/AN/AN/AOLYOlympia Financial GroupC$7.205.50%N/A70.86%N/AURBUrbanaC$0.121.66%N/A7.09%N/ALatest GMN, OLY, AIM, and URB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/20/2025OLYOlympia Financial GroupMonthlyC$0.605.76%8/20/20258/29/20258/29/20257/22/2025OLYOlympia Financial GroupMonthlyC$0.605.95%7/22/20257/31/20257/31/20256/19/2025OLYOlympia Financial GroupMonthlyC$0.606.28%6/19/20256/30/20256/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIMAIM ImmunoTech0.050.750.75GMNGobiMin0.5833.6331.98OLYOlympia Financial Group6.003.321.59URBUrbanaN/AN/A0.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMAIM ImmunoTech12.02%GMNGobiMinN/AOLYOlympia Financial Group1.17%URBUrbana9.55%Insider OwnershipCompanyInsider OwnershipAIMAIM ImmunoTech0.02%GMNGobiMinN/AOLYOlympia Financial Group34.63%URBUrbana57.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMAIM ImmunoTech20764,00068.74 millionNot OptionableGMNGobiMinN/A49.06 millionN/ANot OptionableOLYOlympia Financial Group3252.41 millionN/ANot OptionableURBUrbana240.25 millionN/ANot OptionableGMN, OLY, AIM, and URB HeadlinesRecent News About These CompaniesCarle inviting Urbana residents to join patient and family advisory councilsAugust 22 at 10:46 PM | wandtv.comWShrek The Musical JR. At Urbana High School TheatreAugust 22 at 10:46 PM | msn.comUrbana accident sends 2 state troopers to hospitalAugust 22 at 10:46 PM | news-gazette.comNState Police squad car wrecked in early morning Urbana crashAugust 22 at 10:46 PM | msn.comTwo state troopers hospitalized after crash in UrbanaAugust 22 at 10:46 PM | wandtv.comWChevy hits Illinois State Police car in Urbana, injuring 2 troopersAugust 22 at 10:46 PM | newschannel20.comN'A real tragedy': Community speaks out against OSF's plan to cut services in UrbanaAugust 22 at 7:26 AM | news-gazette.comN'I love being a police officer': Urbana sergeant gives behind-the-scenes look into his jobAugust 22 at 2:11 AM | msn.comIllinois Extension youth crop scouting competition grows interest in agricultural careersAugust 22 at 2:11 AM | extension.illinois.eduEYoung chefs cook up culture at Urbana FarmsteadAugust 22 at 2:11 AM | arkansasonline.comAUPDATE: Two mobile homes destroyed in Urbana fire, no one hurtAugust 22 at 2:11 AM | msn.com'I love being a police officer': Urbana sergeant gives behind-the-scenes look into his job while battling staffing challenges, prioritizing communityAugust 22 at 2:11 AM | yahoo.comTwo trailers destroyed in Urbana fire, no one hurtAugust 22 at 2:11 AM | yahoo.comTwo arrested after Champaign Co. Drug BustAugust 20 at 11:26 PM | wdtn.comWCommunity back-to-school fair set for Aug. 31August 20 at 6:26 PM | news-gazette.comNOSF cuts to Urbana hospital have already begunAugust 20 at 6:26 PM | news-gazette.comNDiscover the Champaign County Historical Archives at the Urbana Free LibraryAugust 20 at 6:26 PM | yahoo.comPublic hearing set for August on OSF's proposal to combine Urbana, Danville servicesAugust 19, 2025 | foxillinois.comF2 arrested in connection with large drug bust in UrbanaAugust 19, 2025 | yahoo.comUrbana PD's new crisis team aims to improve mental health crisis responseAugust 19, 2025 | wandtv.comWUrbana (TSE:URB) Trading Up 1% - Time to Buy?August 5, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Stocks With Monopoly Power—and Minimal CompetitionBy Gabriel Osorio-Mazilli | August 10, 2025How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go?By Jordan Chussler | August 14, 2025Alphabet Reclaims $200 Threshold—Bull Run Reignited?By Ryan Hasson | August 12, 2025AI Glasses to Replace Smartphones? Meta Is Taking Aim at AppleBy Leo Miller | August 16, 2025GMN, OLY, AIM, and URB Company DescriptionsAIM ImmunoTech NYSE:AIM$2.70 +0.01 (+0.37%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.67 -0.03 (-1.11%) As of 08/22/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.GobiMin CVE:GMNC$1.83 0.00 (0.00%) As of 03/8/2023GobiMin Inc., together with its subsidiaries, engages in investment in equity, debt, or other securities in China. The company operates in two segments, Investment Business and Mining Business. It is also involved in the property investment, holding, and leasing activities; and development, exploration, and exploitation of gold property, as well as provision of business and consultancy services. The company is based in Montreal, Canada. GobiMin Inc. operates as a subsidiary of Belmont Holdings Group Limited.Olympia Financial Group TSE:OLYC$131.00 -0.71 (-0.54%) As of 08/22/2025 03:56 PM EasternOlympia Financial Group Inc is engaged in providing financial services. The company's operating segments are Private Health Services Plan division which markets, sells and administers health and dental benefits to business owners; Investment Account Services division specializes in registered account administration; The Currency and Global Payments division provides corporations and private clients a personalized service for buying and selling foreign currencies; The Exempt Edge division is focused on Onboarding fees; The Corporate and Shareholder Services division, which acts as a cost centre and the Corporate Division.Urbana TSE:URBC$7.25 -0.04 (-0.55%) As of 08/22/2025 04:00 PM EasternThe Corporations objectives are to seek out and invest in private investment opportunities for capital appreciation and to invest in publicly traded securities to provide growth, income and liquidity. For the foreseeable future, the strategy of Urbana is to continue to search for and acquire investments for income and capital appreciation within the financial services industry. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access